Business
Directorate Change
Directorate Change.
About this update from Krm22 Plc
[{"type":"text","content":"\n \nRNS Number : 7962R KRM22 PLC 05 March 2019 \n\n \nKRM22 plc\n \n(\"KRM22\" or the \"Company\")\n \nKRM22 Non-Executive Director steps down\n \nKRM22 plc (AIM: KRM), the technology and software investment company, with a particular focus on risk management in capital markets, announces that Jim Oliff has resigned from his role as non-executive director. Jim was diagnosed with cancer in 2018 and has made the decision to step down from his role as non-executive director while he undergoes treatment.\n \nJim Oliff said 'It is with deep regret that I must resign from the board of KRM22. I am in the final stages of treatment for cancer which prevents me from giving the time, attention and focus that both management and the shareholders deserve. I remain very optimistic that the company is on the right path and that it is providing unique value to the financial services industry'. \n \nKeith Todd, CEO at KRM22, said, \"Jim has brought a wealth of industry knowledge and experience to the KRM22 board, and we wish him very well in his treatment and recovery.\"\n \nFor further information please contact:\n \nKRM22 plc via FTI Consulting LLP\nKeith Todd CBE, Executive Chairman and CEO\nKaren Bach, COO\n \nfinnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500\nCarl Holmes / Kate Bannatyne\n \nFTI Consulting LLP ...